Search Results - Thomas Mürdter
- Showing 1 - 3 results of 3
-
1
Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone by Simeon Rüdesheim, Dominik Selzer, Thomas Mürdter, Svitlana Igel, Reinhold Kerb, Matthias Schwab, Thorsten Lehr
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen by Werner Schroth, Werner Schroth, Stefan Winter, Stefan Winter, Thomas Mürdter, Thomas Mürdter, Elke Schaeffeler, Elke Schaeffeler, Diana Eccles, Bryony Eccles, Balram Chowbay, Balram Chowbay, Balram Chowbay, Chiea C. Khor, Chiea C. Khor, Chiea C. Khor, Arafat Tfayli, Nathalie K. Zgheib, Michel Eichelbaum, Michel Eichelbaum, Michel Eichelbaum, Matthias Schwab, Matthias Schwab, Matthias Schwab, Matthias Schwab, Hiltrud Brauch, Hiltrud Brauch, Hiltrud Brauch
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)‐Endoxifen in Breast Cancer by Jeanine Marie Nardin, Werner Schroth, Thais Abreu Almeida, Thomas Mürdter, Solane Picolotto, Evelyn Castillo Lima Vendramini, Reiner Hoppe, Jenifer Primon Kogin, Diandra Miqueleto, Silvia Dark Robaskievicz deMoraes, Matthias Schwab, Roberto Flavio Pecoits‐Filho, Hiltrud Brauch, José Claudio Casali‐da‐Rocha
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book